CYBRD1 and central nervous system cancer: Then, the protein content and distribution of CYBRD1 were subsequently examined in glioma tissues (WHO II/III/IV) and nonglioma normal tissues by IHC staining, as shown in Figure 2(b); CYBRD1-positive cells increased with the grade.